Overview
- CME announced June 17 that long-serving CEO Terry Duffy will step down as CEO and become executive chairman, with President and CFO Lynne Fitzpatrick named to succeed him.
- The leadership change is set to take effect on March 1, 2027 or on the date the company files its annual 10-K, whichever is later, per the company’s securities filing.
- Fitzpatrick is a roughly 20-year CME veteran who has served as president and chief financial officer and will receive a reported $1.2 million base salary plus sizable annual and long‑term incentive opportunities disclosed in the SEC filing.
- Duffy’s multi‑decade tenure included overseeing CME’s shift from pit trading to electronic markets and major deals such as the CBOT merger and NYMEX purchase, and he will remain active during the transition to support continuity.
- The company framed the change as a steady handover that keeps leadership in place while CME expands trading products and tech ties, including work on cryptocurrency derivatives and proposed single‑stock futures that still require regulatory approval.